Sharp NEC Display Solutions Introduces New Widescreen Desktop
Optimized for multi-display set ups, the MultiSync® EA242WU delivers maximum productivity in today’s hybrid workspaces…
Month: September 2022
EDF Renewables North America Signs Agreement with McDonald’s Corporation for Apollo Solar Project
Project will generate low-carbon energy to meet the consumption of over 1,200 U.S. McDonald’s restaurants…
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Upstart Holdings, Inc.’s Directors and Officers for Breach of Fiduciary Duties – UPST
NEW YORK–(BUSINESS WIRE)–Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation…
Warner Thomas takes new role as President & CEO of Sutter Health, Pete November named Ochsner Health CEO
NEW ORLEANS–(BUSINESS WIRE)–Today, Ochsner Health’s Board of Directors announced that after 24 years of service…
Etiya deploys Network Commerce and Management Platform utilizing Amazon Web Services
Amsterdam – Etiya, a leading Independent Software Provider, today announced a collaboration with Amazon Web…
Merchants United Joins With Nroad In Game-Changing Automation Of Merchant Statements
The partnership further transforms the way payment processing and lending companies analyze merchant documents. BOSTON,…
Palisade Bio to Present at the Virtual Investor Innovations in Intestinal Health – Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event
Live moderated video webcast with members of Management to discuss pivotal Phase 3 study of…
Palisade Bio to Present at the Virtual Investor Innovations in Intestinal Health – Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event
Live moderated video webcast with members of Management to discuss pivotal Phase 3 study of…
Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists
Patent Covers Jet Delivery of GLP-1 Receptor Agonists to the Small Intestine for Treatment of…
Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists
Patent Covers Jet Delivery of GLP-1 Receptor Agonists to the Small Intestine for Treatment of…
AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer
LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT),…
AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer
LONDON and PHOENIX, Ariz., Sept. 13, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT),…
Umoja Biopharma Appoints Igor I. Slukvin, M.D., Ph.D. to its Scientific Advisory Board
SEATTLE, Sept. 13, 2022 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf,…
Umoja Biopharma Appoints Igor I. Slukvin, M.D., Ph.D. to its Scientific Advisory Board
SEATTLE, Sept. 13, 2022 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf,…
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001
Collaboration leverages Nacuity’s NPI-001 for the treatment of fatal rare disease HCCAA in Iceland FORT…
Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001
Collaboration leverages Nacuity’s NPI-001 for the treatment of fatal rare disease HCCAA in Iceland FORT…
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
— Expected to be accretive to 2023 earnings — DEER PARK, Ill., Sept. 13, 2022…
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
— Expected to be accretive to 2023 earnings — DEER PARK, Ill., Sept. 13, 2022…